Holen Sie sich die Stockscreener-App
35.78
0.34%
0.13
Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten
Citigroup Issues Positive Forecast for Royalty Pharma (NASDAQ:RPRX) Stock Price - MarketBeat
Citigroup maintains Buy rating, raises PT for Royalty Pharma to $42. - AInvest
Citi raises Royalty Pharma stock price target to $42 on CF and Tremfya growth - Investing.com UK
Royalty Pharma (RPRX) PT Raised to $42 at Citi - StreetInsider
What drives Royalty Pharma plc stock priceFree Technical Analysis Support - jammulinksnews.com
What analysts say about Royalty Pharma plc stockOver 200% growth - jammulinksnews.com
C WorldWide Group Holding A S Acquires New Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Los Angeles Capital Management LLC Purchases 1,040,234 Shares of Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Edgestream Partners L.P. Acquires New Stake in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc Stock Analysis and ForecastConsistent triple returns - Autocar Professional
Royalty Pharma PLC (NASDAQ:RPRX) Stake Raised by Victory Capital Management Inc. - MarketBeat
Is Royalty Pharma plc a good long term investmentFree Trend-Following Techniques - jammulinksnews.com
Morgan Stanley Raises Royalty Pharma (RPRX) Price Target, Maintains Overweight Rating - MSN
Royalty Pharma (NASDAQ:RPRX) Reaches New 52-Week HighTime to Buy? - MarketBeat
Cullen Frost Bankers Inc. Has $7.72 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Declares Q3 2025 Dividend of $0.22 per Class A Share - AInvest
Cerity Partners LLC Has $4.79 Million Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Declares Q3 2025 Dividend of $0.22 per Class A Ordinary Share - AInvest
Royalty Pharma PLC Announces Quarterly Dividend of $0.22 (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Declares Third Quarter 2025 Dividend - The Globe and Mail
Royalty Pharma announces $0.22 per share dividend for Q3 2025 - Investing.com
Royalty Pharma plc (RPRX) Declares $0.22 Quarterly Dividend; 2.5% Yield - StreetInsider
Royalty Pharma Announces Q3 2025 Dividend of $0.22 per Share - AInvest
How to Take Advantage of moves in (RPRX) - news.stocktradersdaily.com
Bryn Mawr Capital Management LLC Boosts Stock Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Is Royalty Pharma plc stock a good hedge against inflationHigh Potential Safe Trades - Newser
Royalty Pharma adds two independent directors to board By Investing.com - Investing.com South Africa
Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company’s Board of Directors - The Manila Times
Royalty Pharma adds two independent directors to board - Investing.com
Royalty Pharma Appoints Two New Independent Directors, Boosting Independent Board Representation to Over 90% - Quiver Quantitative
Royalty Pharma Appoints Denali CMO and Warburg Pincus Veteran to Board Following Major Acquisition - Stock Titan
Strata Wealth Advisors LLC Invests $387,000 in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Bank of New York Mellon Corp Has $45.53 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025 - The Manila Times
Royalty Pharma Q2 2025 Earnings Call: Key Details for August 6 Pre-Market Release - Stock Titan
Why Royalty Pharma plc stock attracts strong analyst attentionDaily Swing Candidates - Newser
How Royalty Pharma plc stock performs during market volatilityMarket Timing Advice - beatles.ru
What makes Royalty Pharma plc stock price move sharplyFree Trading Group - Newser
M&T Bank Corp Increases Stock Position in Royalty Pharma PLC (NASDAQ:RPRX) - Defense World
Fiera Capital Announces the Termination of imaxx Canadian Fixed Pay Fund and of imaxx Short Term Bond Fund - The Globe and Mail
0.39%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):